BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2988117)

  • 1. [Acquired immunodeficiency syndrome (AIDS). An update after 4 years].
    Vogt M; Lüthy R; Siegenthaler W
    Schweiz Med Wochenschr; 1985 May; 115(19):665-71. PubMed ID: 2988117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS: The challenge to science and medicine.
    Krim M
    Hastings Cent Rep; 1985 Aug; 15(4):suppl 2-7. PubMed ID: 2997085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acquired immunodeficiency syndrome, Kaposi's disease and cerebral toxoplasmosis in a young man. Review of the literature apropos of a case].
    Janier M; Perroud AM; Revuz J; Wechsler J; Feuilhade M; Poirier J; Caron JP; Touraine R
    Ann Dermatol Venereol; 1984; 111(1):11-23. PubMed ID: 6375520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS in Haitian-Americans: a reassessment.
    Frank E; Weiss SH; Compas JC; Bienstock J; Weber J; Bodner A; Landesman SH
    Cancer Res; 1985 Sep; 45(9 Suppl):4619s-4620s. PubMed ID: 2990695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-III infection in Canada in 1985.
    Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
    CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti.
    Pape JW; Liautaud B; Thomas F; Mathurin JR; St Amand MM; Boncy M; Pean V; Pamphile M; Laroche AC; Johnson WD
    N Engl J Med; 1983 Oct; 309(16):945-50. PubMed ID: 6621622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update: acquired immunodeficiency syndrome--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):17-21. PubMed ID: 3079867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):373-5. PubMed ID: 2989677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kaposi sarcoma in acquired immune deficiency syndrome (AIDS). I: Clinical findings and laboratory diagnosis].
    Weidauer H; Hofmann H
    Laryngol Rhinol Otol (Stuttg); 1985 Aug; 64(8):418-22. PubMed ID: 2995739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS: a challenge for the public health.
    Acheson ED
    Lancet; 1986 Mar; 1(8482):662-6. PubMed ID: 2869356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
    Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
    N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key epidemiologic questions about AIDS and infection with HTLV-III/LAV.
    Hopkins DR
    Public Health Rep; 1986; 101(3):234-7. PubMed ID: 3012620
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AIDS epidemic in New York City, 1981-1984. New York City Department of Health AIDS Surveillance.
    Am J Epidemiol; 1986 Jun; 123(6):1013-25. PubMed ID: 3706272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological trends of AIDS in the United States.
    Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
    Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.